2714436-53-8
2714436-53-8
Chemical Structure
Emtricitabine-15N,d2
Synonym(s): BW1592-15N,d2
- CAS No.: 2714436-53-8
- Formula:C8H8D2FN215NO3S
- Molecular Weight:250.25
IUPAC Name: 4-(amino-15N)-5-fluoro-1-((2R,5S)-2-(hydroxymethyl-d2)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
InChIKey: XQSPYNMVSIKCOC-SOECANAFSA-N
SMILES: O=C1N(C=C(C([15NH2])=N1)F)[C@@]2([H])O[C@H](SC2)C([2H])([2H])O
Biological Activity: Emtricitabine-15N,d2 is a 15N-labeled and deuterium labeled Emtricitabine. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Emtricitabine-15N,d2 | 97.64% | Emtricitabine-15N,d2 is a 15N-labeled and deuterium labeled Emtricitabine. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine (Standard) | 99.98% | Emtricitabine (Standard) is the analytical standard of Emtricitabine. This product is intended for research and analytical applications. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine-13C,15N2 | Emtricitabine-13C,15N2 (BW1592-13C,15N2) is a 13C- and 15N-labeled Emtricitabine (HY-17427). Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine-d2 | Emtricitabine-d2 (BW1592-d2) is deuterium labeled Emtricitabine. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine | 99.97% | Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
